Skip to Content

Pomalidomide

In the US, Pomalidomide (pomalidomide systemic) is a member of the following drug classes: miscellaneous antineoplastics, other immunosuppressants and is used to treat Multiple Myeloma.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L04AX06

CAS registry number (Chemical Abstracts Service)

0019171-19-8

Chemical Formula

C13-H11-N3-O4

Molecular Weight

273

Therapeutic Category

Antineoplastic agent

Chemical Name

4-amino-2-[(3RS)-2,6-dioxopiperidin-3-yl]-2H-isoindole-1,3-dione (WHO)

Foreign Names

  • Pomalidomidum (Latin)
  • Pomalidomid (German)
  • Pomalidomide (French)
  • Pomalidomida (Spanish)

Generic Names

  • Pomalidomide (OS: USAN)
  • CC-4047 (IS)
  • IMiD 3 (IS)
  • UNII-D2UX06XLB5 (IS)

Brand Names

  • Imnovid
    Celgene, Belgium; Celgene, Switzerland; Celgene, Spain; Celgene, Finland; Celgene, France; Celgene, United Kingdom; Celgene, Ireland; Celgene, Israel; Celgene, Italy; Celgene, Norway; Celgene, Poland; Celgene, Sweden; Celgene Europe, Denmark; Celgene Europe, Slovenia
  • IMNOVID
    Celgene, Germany
  • Pomalidomida Celgene
    Celgene, Spain
  • Pomalyst
    Celgene, United States

International Drug Name Search

Glossary

TermDefinition
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide